Just weeks af­ter he stepped down as chair­man, Emer­gen­t's for­mer CEO dies at age 64

The Santa Monica, CA-based biotech’s stock shot up early Friday on reports that it had agreed to a licensing deal with Hikma Pharmaceuticals on an experimental nasal spray to treat opioid overdoses.